Meeting Coverage:

Aspen Retinal Detachment Society

ARDS: 2022

The Promise of Dry AMD Therapies

Show Description +

The pipeline for dry AMD is exciting, with several therapeutics inching toward approval, according to Dr. Miller.

Posted: 3/25/2022

Up Next

PDS Implantation Tips and Tricks

Carl C. Awh, MD, FASRS

Gene Therapy for IRDs: The How and Why of Imaging

Aleksandra Rachitskaya, MD; and Timothy G. Murray, MD, MBA

Advances in Diabetic Eye Disease Management

Judy E. Kim, MD; and Timothy G. Murray, MD, MBA

Clinical Insights from High-Resolution OCT

K. Bailey Freund, MD; Timothy Murray, MD

Complex RD? Consider Medium-Term PFO

Steve Charles, MD, FACS, FICS

Advances in Ocular Oncology

Timothy G. Murray, MD, MBA

The Promise of Dry AMD Therapies

The pipeline for dry AMD is exciting, with several therapeutics inching toward approval, according to Dr. Miller.

Posted: 3/25/2022


Please log in to leave a comment.

More From ARDS: 2022 Coverage

Gene Therapy for IRDs: The How and Why of Imaging

Aleksandra Rachitskaya, MD; and Timothy G. Murray, MD, MBA

Advances in Diabetic Eye Disease Management

Judy E. Kim, MD; and Timothy G. Murray, MD, MBA

Clinical Insights from High-Resolution OCT

K. Bailey Freund, MD; Timothy Murray, MD

Complex RD? Consider Medium-Term PFO

Steve Charles, MD, FACS, FICS